Breast Biopsy Market Size, Share, Growth Analysis, By Product (Biopsy Needles, Core Needles), By Indication (Complex Cysts, Solid Mass), By End User (Hospitals, Specialty Clinics), By Region - Industry Forecast 2024-2031

Global Breast Biopsy Market size was valued at USD 842.1 million in 2022 and is poised to grow from USD 911.15 million in 2023 to USD 1711.63 million by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031). 

The global breast biopsy market is a dynamic and rapidly growing sector within the healthcare industry. It encompasses a range of diagnostic procedures that are used to assess and analyze breast tissue for the presence of abnormalities or potential breast cancer. The market is driven by various factors, including the increasing incidence of breast cancer worldwide, rising awareness about early detection and diagnosis, technological advancements in imaging modalities and biopsy techniques, and growing demand for minimally invasive procedures. The market offers a diverse range of biopsy methods, including core needle biopsy, vacuum-assisted biopsy, fine needle aspiration, and surgical biopsy. Additionally, there is a rising trend toward the adoption of image-guided biopsy procedures, such as ultrasound-guided, mammography-guided, and magnetic resonance imaging (MRI)-guided biopsies, as they offer improved accuracy and precision. Furthermore, the market is witnessing the development of innovative biopsy devices and systems, including automated biopsy guns, handheld biopsy devices, and stereotactic biopsy systems, which enhance procedural efficiency and patient comfort. Geographically, North America dominated the global market, attributed to the high prevalence of breast cancer, well-established healthcare infrastructure, and favorable reimbursement policies. However, emerging economies in Asia-Pacific and Latin America are expected to witness significant growth in the coming years due to increasing healthcare expenditure, improving healthcare facilities, and rising awareness about breast cancer screening. In conclusion, the global breast biopsy market is poised for substantial growth as healthcare systems focus on early detection and accurate diagnosis of breast cancer, leading to improved patient outcomes and reduced mortality rates.

US Breast Biopsy Market is poised to grow at a sustainable CAGR for the next forecast year.